Jane Street’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Jane Street’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-633,932	Closed	-$13.5M	–	10428
2024 Q1	$13.5M	Buy	633,932 +605,800	+2,153%	+$7.25M	﹤0.01%	1519
2023 Q4	$270K	Buy	+28,132	New	+$137K	﹤0.01%	7764

Jane Street's FUSN Position: Q2 2024 in Review

Jane Street sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 633,932 shares — an estimated $13.5M sold.

Jane Street first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $13.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Jane Street reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Jane Street sold 633,932 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $13.5M.
Jane Street first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Jane Street's Fusion Pharmaceuticals Inc. Common Shares position peaked at $13.5M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.